GYBYS(SH:600332)2024-09-20 09:47Group 1: Dividend Policy - The company plans to implement a mid-year profit distribution plan for 2024, distributing a cash dividend of 4 CNY per 10 shares, totaling approximately 650 million CNY [2][7] - The company aims to ensure that the total cash dividends distributed (including mid-year dividends) will not be less than 30% of the net profit attributable to the parent company for the year [3][7] Group 2: Financial Management - The company has taken effective measures to manage accounts receivable and optimize inventory management, addressing the rising trend of accounts receivable and inventory since 2017 [3][4] - The company has been conducting accounts receivable asset securitization financing since 2021 to enhance asset liquidity and improve capital efficiency [3][4] Group 3: Product Marketing and Sales - The company plans to improve the marketing of its products, such as "Li Xiao Ji" and "Ci Ning Ji," by enhancing sales strategies across different channels and optimizing digital marketing efforts [4][5] - The retail pharmacy business has 157 outlets as of December 31, 2023, with a focus on prescription drug retail and community pharmacies [5][6] Group 4: Market Performance and Investor Relations - The company emphasizes the importance of market value management and has organized multiple roadshows and strategy meetings to enhance communication with investors [6][8] - The company has no current plans for share buybacks or acquisitions, but will disclose any future plans according to listing regulations [5][6]